FR2445338A1 - Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennent - Google Patents
Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennentInfo
- Publication number
- FR2445338A1 FR2445338A1 FR7927645A FR7927645A FR2445338A1 FR 2445338 A1 FR2445338 A1 FR 2445338A1 FR 7927645 A FR7927645 A FR 7927645A FR 7927645 A FR7927645 A FR 7927645A FR 2445338 A1 FR2445338 A1 FR 2445338A1
- Authority
- FR
- France
- Prior art keywords
- onco
- preparation
- rna virus
- same
- vaccines containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 3
- 108090000288 Glycoproteins Proteins 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 101800001271 Surface protein Proteins 0.000 abstract 3
- 101800001467 Envelope glycoprotein E2 Proteins 0.000 abstract 2
- 241000714165 Feline leukemia virus Species 0.000 abstract 2
- 241000282326 Felis catus Species 0.000 abstract 1
- 102100040510 Galectin-3-binding protein Human genes 0.000 abstract 1
- 241000714177 Murine leukemia virus Species 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 102100025055 NTF2-related export protein 1 Human genes 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 abstract 1
- 238000001114 immunoprecipitation Methods 0.000 abstract 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13061—Methods of inactivation or attenuation
- C12N2740/13063—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/819—Viral vaccine for feline species, e.g. cats
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Glycoprotéine non dénaturée appelée (gp90), isolée d'enveloppes d onco-RNA virus. Elle a une masse moléculaire de 90 000 daltons, elle est formée d'unités de la glycoprotéine gp70 et de la protéine p15 (E), elle est susceptible d'immunoprécipitation avec des sérums anti-gp70 et anti-pl5 (E), elle donne la gp70 et la p15 (E) par réduction avec le mercapto-éthanol, et, en solution aqueuse et en présence de détergents non ioniques, elle se trouve sous la forme d'un complexe ayant une masse moléculaire de 360 000 à 450 000. Elle peut être obtenue à partir du virus de la leucémie féline ou de la leucémie murine. Utilisation dans des vaccins pour la protection du chat contre le virus de la leucémie féline.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/973,958 US4406885A (en) | 1978-12-28 | 1978-12-28 | Preparation of native oncornavirus envelope subunits and vaccines therefrom |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2445338A1 true FR2445338A1 (fr) | 1980-07-25 |
FR2445338B1 FR2445338B1 (fr) | 1983-06-17 |
Family
ID=25521412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7927645A Granted FR2445338A1 (fr) | 1978-12-28 | 1979-11-09 | Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennent |
Country Status (5)
Country | Link |
---|---|
US (1) | US4406885A (fr) |
CA (1) | CA1156647A (fr) |
DE (1) | DE2951509A1 (fr) |
FR (1) | FR2445338A1 (fr) |
GB (1) | GB2038338B (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0030728A2 (fr) * | 1979-12-18 | 1981-06-24 | The Ohio State University Research Foundation | Vaccin contre la leucémie féline |
WO1985002625A1 (fr) * | 1983-12-09 | 1985-06-20 | Cetus Corporation | Vaccin du virus de la leucemie chez les felins |
EP0247904A1 (fr) * | 1986-05-30 | 1987-12-02 | Cambridge Biotech Corporation | Méthode de préparation et utilisation d'antigènes du virus de la leucémie des chats |
US5352449A (en) * | 1986-05-30 | 1994-10-04 | Cambridge Biotech Corporation | Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4434157A (en) | 1979-12-18 | 1984-02-28 | The Ohio State University Research Foundation | Method of recovering cell antigen and preparation of feline leukemia vaccine therefrom |
ZA84617B (en) * | 1983-02-14 | 1984-09-26 | Arup Sen | Synthetic polypeptides from viryl oncogenes |
US4743678A (en) * | 1983-04-27 | 1988-05-10 | President And Fellows Of Harvard College | Method and products for detection of human T cell leukemia virus |
US4933179A (en) * | 1983-08-22 | 1990-06-12 | Syntex (U.S.A.) Inc. | Feline leukemia virus antigen vaccines |
US5152982A (en) * | 1984-03-26 | 1992-10-06 | Chiron Corporation | Compositions and methods for FeLV vaccination |
US4663436A (en) * | 1984-04-24 | 1987-05-05 | Scripps Clinic And Research Foundation | Leukemia-associated virus immunogen, vaccine and assay |
US4789702A (en) * | 1984-05-18 | 1988-12-06 | Cetus Corporation | Feline leukemia virus vaccine |
US5510238A (en) * | 1984-10-26 | 1996-04-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Production of human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein fragments in bacteria and use in seroepidemiological studies |
DK155886D0 (da) * | 1986-04-04 | 1986-04-04 | Bo Arne Hofmann | Vaccine og fremgangsmaade til fremstilling af denne |
DE68924478T2 (de) * | 1988-12-13 | 1996-03-07 | Univ Colorado Res | Prototypische FeLV-Isolate für die Verwendung als Krankheitsmuster oder Impfstoffe. |
EP0621893A4 (fr) * | 1992-01-06 | 1995-07-12 | Smithkline Beecham Corp | Vaccins contre le virus de la leucemie des felins. |
US5633234A (en) * | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
JP4236279B2 (ja) * | 1993-05-24 | 2009-03-11 | ズィメレックス・インコーポレーテッド | 異種移植に対する寛容性の発現のための代理寛容形成 |
EP1638587A4 (fr) | 2003-02-14 | 2007-04-18 | Univ Missouri | Methodes et compositions contraceptives associees aux interferences des proteasomes |
-
1978
- 1978-12-28 US US05/973,958 patent/US4406885A/en not_active Expired - Lifetime
-
1979
- 1979-11-08 GB GB7938783A patent/GB2038338B/en not_active Expired
- 1979-11-09 FR FR7927645A patent/FR2445338A1/fr active Granted
- 1979-11-14 CA CA000339803A patent/CA1156647A/fr not_active Expired
- 1979-12-20 DE DE19792951509 patent/DE2951509A1/de not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
EXBK/78 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0030728A2 (fr) * | 1979-12-18 | 1981-06-24 | The Ohio State University Research Foundation | Vaccin contre la leucémie féline |
EP0030728A3 (en) * | 1979-12-18 | 1981-12-23 | The Ohio State University Research Foundation | Feline leukemia vaccine |
WO1985002625A1 (fr) * | 1983-12-09 | 1985-06-20 | Cetus Corporation | Vaccin du virus de la leucemie chez les felins |
EP0247904A1 (fr) * | 1986-05-30 | 1987-12-02 | Cambridge Biotech Corporation | Méthode de préparation et utilisation d'antigènes du virus de la leucémie des chats |
US5352449A (en) * | 1986-05-30 | 1994-10-04 | Cambridge Biotech Corporation | Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant |
Also Published As
Publication number | Publication date |
---|---|
CA1156647A (fr) | 1983-11-08 |
FR2445338B1 (fr) | 1983-06-17 |
US4406885A (en) | 1983-09-27 |
DE2951509A1 (de) | 1980-07-17 |
GB2038338A (en) | 1980-07-23 |
GB2038338B (en) | 1982-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2445338A1 (fr) | Preparation de glycoproteine isolee d'enveloppes d'onco-rna virus et vaccins qui la contiennent | |
Moss et al. | Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin | |
Rushbrook et al. | Comparison of adult, embryonic, and dystrophic myosin heavy chains from chicken muscle by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and peptide mapping. | |
Yoshinaka et al. | Bovine leukemia virus protease: purification, chemical analysis, and in vitro processing of gag precursor polyproteins | |
IE832394L (en) | Immunogenic protein or peptide complex vaccine. | |
KR880700068A (ko) | 임파선증 관련비루스(lav)의 게놈성 rna와 혼성화될 수 있는, 클론화된 dna 서열 | |
DK33190A (da) | Hiv-3 retrovirus og anvendelse heraf | |
FR2389637A1 (fr) | ||
DE59504181D1 (de) | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung | |
PT102022A (pt) | Processo para a producao e purificacao de astaloglicoprotetinas adequadas para uso em vacinas e conjunto de materiais de ensaio para detectar a sua presenca | |
DE59410380D1 (de) | Endosomolytisch wirksame partikel | |
DE69929612D1 (de) | Purifikation von viruspräparaten | |
PT83255B (pt) | Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus | |
EP0554389A4 (en) | Molecular clones of hiv-1 and uses thereof | |
BR9811675A (pt) | Genes isolados para proteìna da membrana de célula dentrìtica | |
KR910019641A (ko) | 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프 | |
Kalan et al. | Action of rennin on κ-casein, the amino acid compositions of the para-κ-casein, and glycomacropeptide fractions | |
Deshayes et al. | Proteins of bovine leukemia virus. I. Characterization and reactions with natural antibodies | |
Shelton et al. | In vitro oxidation of intrinsic sulfhydryl groups yields polymers of the two predominant polypeptides in the nuclear envelope fraction | |
Van Eldik et al. | The influence of carbohydrate on the antigenicity of the envelope glycoprotein of avian myeloblastosis virus and B77 avian sarcoma virus | |
KR890013176A (ko) | 사람 면역결핍 바이러스 타입 1의 외막 유전자로부터 유도된 폴리펩타이드를 함유하는 백신 | |
KR860001882A (ko) | 왁진 효능이 있는 폴리펩타이드 | |
KR900702045A (ko) | 천연 hiv gp 160의 제조방법 | |
Moore et al. | A comparative study of the polypeptides of three iridescent viruses by N-terminal analysis, amino acid analysis, and surface labeling | |
FR2600079B1 (fr) | Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |